Healthcare - Medical - Devices - NASDAQ - US
$ 12.64
1.36 %
$ 556 M
Market Cap
-38.3
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
17.55%
EBIT
Estimate
--29.68%
Net Income
Estimate
41.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AxoGen, Inc.
AXGN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart AXGN
EBIT FORECAST
EBIT Forecast Chart AXGN
NET INCOME FORECAST
Net Income Chart AXGN